Global Intravenous Solutions Market Size study & Forecast, by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition) by Solution Composition (Saline, Carbohydrates, Vitamins and Minerals, Other Solution Compositions) and Regional Analysis, 202

Global Intravenous Solutions Market Size study & Forecast, by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition) by Solution Composition (Saline, Carbohydrates, Vitamins and Minerals, Other Solution Compositions) and Regional Analysis, 2022-2029

Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.

Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.

Major market player included in this report are:
Amanta Healthcare Ltd.
Axa Parenterals Ltd.
B. Braun Melsungen AG
Baxter International Inc.
Dickinson and Company
Eurolife Healthcare Pvt Ltd.
Fresenius Kabi AG
Grifols S.A
Henry Schein Inc.
ICU Medical, Inc.

Recent Developments in the Market:
In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.

Global Intravenous Solutions Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Solution Composition, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Total Parenteral Nutrition
Peripheral Parenteral Nutrition
By Solution Composition:
Saline
Carbohydrates
Vitamins and Minerals
Other Solution Compositions

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Amanta Healthcare Ltd.
Axa Parenterals Ltd.
B. Braun Melsungen AG
Baxter International Inc.
Dickinson and Company
Eurolife Healthcare Pvt Ltd.
Fresenius Kabi AG
Grifols S.A
Henry Schein Inc.
ICU Medical, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.